Beom Jin Kim

Beom Jin Kim

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
MJMoon Kyung Joo
Moon Kyung Joo
CPChan Hyuk Park
Chan Hyuk Park
JKJoon Sung Kim
Joon Sung Kim
JPJae Myung Park
Jae Myung Park
JAJi Yong Ahn
Ji Yong Ahn
KRKorean College of Helicobacter Upper Gastrointestinal Research
Korean College of Helicobacter Upper Gastrointestinal Research
Moon Kyung Joo, Chan Hyuk Park, Joon Sung Kim, Jae Myung Park, Ji Yong Ahn, Bong Eun Lee, Jeong Hoon Lee, Hyo-Joon Yang, Yu Kyung Cho, Chang Seok Bang, Beom Jin Kim, Hye-Kyung Jung, Byung-Wook Kim, and Yong Chan Lee, Korean College of Helicobacter and Upper Gastrointestinal Research. Gut and Liver 2020;14:707-26. https://doi.org/10.5009/gnl20246

15 September 2019 in Gut and Liver
Verified
Journal Article
Open access
PDF file
BKBeom Jin Kim
Beom Jin Kim
Hyuk LeeHyuk Lee
Hyuk Lee
YLYong Chan Lee
Yong Chan Lee
SJSeong Woo Jeon
Seong Woo Jeon
Gwang Ha KimGwang Ha Kim
Gwang Ha Kim
KRKorean College of Helicobacter Upper Gastrointestinal Research
Korean College of Helicobacter Upper Gastrointestinal Research
Beom Jin Kim, Hyuk Lee, Yong Chan Lee, Seong Woo Jeon, Gwang Ha Kim, Hyun-Soo Kim, Jae Kyu Sung, Dong Ho Lee, Heung Up Kim, Moo In Park, Il Ju Choi, Soon Man Yoon, Sang Wook Kim, Gwang Ho Baik, Ju Yup Lee, Jin Il Kim, Sang Gyun Kim, Jayoun Kim, Joongyup Lee, Jae Gyu Kim, and Jae J. Kim, Korean College of Helicobacter and Upper Gastrointestinal Research. Gut and Liver 2019;13:531-40. https://doi.org/10.5009/gnl19136

9 March 2017 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
EZEun Young Ze
Eun Young Ze
BKBeom Jin Kim
Beom Jin Kim
Hyun KangHyun Kang
Hyun Kang
JKJae Gyu Kim
Jae Gyu Kim
Background To investigate the association between abdominal fat distribution represented by the visceral fat area (VFA) to subcutaneous fat area (SFA) ratio, and erosive esophagitis (EE). Methods Seven hundred and twenty-eight participants aged >40 years underwent physical examination, blood tests, esophagogastroduodenoscopy, and abdominal computer tomography at Chung-Ang University Hospital from 2007 to 2012. Results Of 728 subjects, 65 (8.9%) had EE. The EE patients had higher body mass index, metabolic syndrome prevalence, triglyceride levels, and blood pressure (P < 0.05). The mean VFA/SFA ratio was higher in the EE group than in the non-EE group (1.30 vs. 0.92, P < 0.001). The predominance of EE in the group with higher VFA/SFA ratio was higher than in the group with lower VFA/SFA ratio (P < 0.001). A VFA/SFA ratio ≥1.165 had good accuracy to predict EE (area under the receiver-operating characteristic curve, 0.643). The VFA/SFA ratio and visceral fat volume were positively correlated with the severity of EE (P = 0.002), and a VFA/SFA ratio ≥1.165 was strongly correlated with the severity of EE (P < 0.001). Conclusion The high VFA/SFA ratio can be a useful clinical predictor of EE.

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
BKBeom Jin Kim
Beom Jin Kim
HKHyun-Soo Kim
Hyun-Soo Kim
HSHyun Joo Song
Hyun Joo Song
ICIl-Kwun Chung
Il-Kwun Chung
Gwang Ha KimGwang Ha Kim
Gwang Ha Kim
URUpper Gastrointestinal Research
Upper Gastrointestinal Research
Kim BJ, et al. J Korean Med Sci. 2016 Aug;31(8):1246-1253. https://doi.org/10.3346/jkms.2016.31.8.1246

7 October 2016 in Nutrition and Cancer
Verified
Journal Article
Closed access
DJDong Hwan Jun
Dong Hwan Jun
BKBeom Jin Kim
Beom Jin Kim
JPJi Hoon Park
Ji Hoon Park
JKJae G. Kim
Jae G. Kim
KCKyong-Choun Chi
Kyong-Choun Chi
Hyun KangHyun Kang
Hyun Kang
Radical gastrectomy followed by adjuvant chemotherapy for advanced gastric cancer causes serious nutritional impairment. Our study evaluated the clinical impact of body mass index (BMI) on the long-term outcomes of advanced gastric cancer (stage II and III). We analyzed 211 cases of stage II and III gastric cancer between January 2005 and December 2010 at Chung-Ang University Hospital, Seoul, Korea. Patients were divided into four groups according to BMI: underweight, normal, overweight, and obese. In addition, we divided patients into two groups: BMI-High (BMI ≥ 23 kg/m2) vs. BMI-Low (BMI < 23 kg/m2). We assessed age, sex, tumor location, lymph node (LN) involvement, operation method, initial cancer stage, recurrence, and survival between the two groups. There was significant difference in overall survival (OS) between the underweight group and the other groups (P = 0.005). The survival of the BMI-High group was better than that of the BMI-Low group. The rate of cancer-related death in the BMI-High group was significantly lower than that in the BMI-Low group (cancer-related death: BMI-Low 27% vs. BMI-High 12.6%, P = 0.022). Our findings suggest that preoperative BMI may have an influence on the long-term outcomes of advanced gastric cancer after radical surgery and chemotherapy.

1 August 2019 in Helicobacter
Verified
Journal Article
Open access
BKBeom Jin Kim
Beom Jin Kim
CYChang‐Hun Yang
Chang‐Hun Yang
HSHyun Joo Song
Hyun Joo Song
SJSeong Woo Jeon
Seong Woo Jeon
GKGwang Ha Kim
Gwang Ha Kim
JKJae Gyu Gyu Kim
Jae Gyu Gyu Kim
Background: The Helicobacter pylori eradication rate has decreased with increasing antibiotic resistance. We conducted a prospective, nationwide, multicenter registry study to monitor the real status of H. pylori eradication therapy and to investigate the association between eradication success and antibiotic use density in Korea.Materials and Methods: We enrolled 9318 patients undergoing H. pylori eradication therapy from 37 hospitals through “on‐line database registry” from October 2010 to July 2015. Demographic data, detection methods, treatment indications, regimens, durations, compliance, adverse events, and eradication results were collected. The use of all commercially available eradication antibiotics was analyzed through the Korean National Health Insurance data of the Health Insurance Review and Assessment Service. The defined daily dose of antibiotics was used to standardize drug use comparisons.Results: Finally, 6738 patients were analyzed. The overall eradication rate of first‐line therapy was 71.8%. The eradication success rates were 71.7%, 86.9%, and 74.0% for standard triple therapy for 7 days, quadruple therapy, and concomitant therapy, respectively. The eradication success rate in naive patients was higher than that in those who previously underwent H. pylori eradication. Eradication success was significantly associated with younger age, female sex, and high compliance. Regional differences in eradication rates were observed. The yearly use density of clarithromycin increased statistically in seven regions across the country from 2010 to 2015. The yearly use density of amoxicillin in the Gyeongsang and Chungcheong areas was significantly increased (P < .01), whereas that of other macrolides was significantly lower in the Gyeonggi area than in other areas (P = .01). The overall use of eradication antibiotics has increased while the eradication rate steadily decreased for 5 years. However, there was no significant correlation between antibiotic use density and eradication.Conclusion: There was no relationship between the eradication rate and antibiotic use density in Korea.